Zentera Therapeutics (Shanghai) Co., Ltd. successful hold investigator meeting for c3ZTCN100

2021-07-03 18:21

➢This meeting was attended by investigators from seven clinical sites, officers from site institutions and stakeholders from relevant vendors.

➢The investigators’ meeting of c3ZTCN100 which was sponsored by Zentera Therapeutics Shanghai Co., Ltd. was successfully held in Shanghai in the morning of July 3rd, 2021. The meeting was conducted in the form of “offline + online”. This meeting was attended by investigator from seven clinical sites, officers from site institutions and stakeholders from relevant vendors. This meeting was the first investigator’ meeting of ZN-c3 R&D pipeline in China and the successful holding of this meeting also laid the foundation for the good cooperation between ZN-c3 pipeline and Chinese clinical sites as well as related vendors.